NewGenIvf Group Receivables

The latest receivables for NIVF is $1.1M as of December 2025. That compares with $1.4M in the prior-year period — down 21.5% year over year. Investors often review this figure alongside NewGenIvf Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, NIVF's receivables moved from $1.4M to $1.1M — a 21.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NewGenIvf Group's operating scale or balance-sheet position.

A receivables figure of $1.1M for NIVF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NIVF's receivables ($1.1M), review year-over-year change from $1.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.